Search Results - "Dubravka Sertić"

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem by Sertić, Zrinka, Lucijanić, Marko, Bašić-Kinda, Sandra, Serventi Seiwerth, Ranka, Periša, Vlatka, Sertić, Dubravka, Coha, Božena, Pulanić, Dražen, Perić, Zinaida, Desnica, Lana, Mikulić, Mirta, Vodanović, Marijo, Radman-Livaja, Ivo, Šegulja, Dragana, Rogić, Dunja, Valković, Toni, Aurer, Igor, Duraković, Nadira

“…Disease- and treatment-mediated immunodeficiency might render SARS-CoV-2 vaccines less effective in patients with hematologic diseases. We performed a…”
Get full text

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma by Aurer, Igor, Nemet, Damir, Mitrović, Zdravko, Dujmović, Dino, Bašić-Kinda, Sandra, Radman, Ivo, Sertić, Dubravka, Šantek, Fedor, Kralik, Marko, Dotlić, Snježana, Mazić, Sanja, Labar, Boris

“…Relapsed/refractory Hodgkin’s lymphoma (HL) is treated with salvage chemotherapy and autologous stem cell transplantation (ASCT). Optimal chemotherapy is…”
Get full text

Croatian Translation of the Horne and Östberg Morningness-Eveningness Questionnaire With a Brief Review of Circadian Typology by Jakov Milić, Ivana Škrlec, Iva Milić Vranješ, Matea Matić, Dubravka Sertić, Marija Heffer

“…Introduction: Horne and Östberg Morningness-Eveningness Questionnaire (MEQ) is a questionnaire widely used to assess the circadian typology. The aim of this…”
Get full text

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients by Batinić, Josip, Perić, Zinaida, Šegulja, Dragana, Last, James, Prijić, Sanja, Dubravčić, Klara, Volarić, Lidija, Sertić, Dubravka, Radman, Ivo, Bašić-Kinda, Sandra, Matišić, Danica, Batinić, Drago, Labar, Boris, Nemet, Damir

“…To evaluate the clinical utility of incorporating a novel heavy/light chain immunoassay (HLC) into the existing methods for the assessment of multiple myeloma…”
Get full text

Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome by Raos, Mirela, Nemet, Damir, Bojanić, Ines, Sertić, Dubravka, Batinić, Drago, Dusak, Vesna, Dubravcić, Klara, Mazić, Sanja, Serventi-Seiwerth, Ranka, Mrsić, Mirando, Golubić-Cepulić, Branka, Labar, Boris

“…Hematopoietic stem cell (HSC) transplantation is a standard approach in the treatment of hematological malignant diseases. For the last 15 years the main…”
Get more information

Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis by Durakovic, Nadira, Radojcic, Vedran, Boban, Ana, Mrsic, Mirando, Sertic, Dubravka, Serventi-Seiwerth, Ranka, Nemet, Damir, Labar, Boris

“…Objective A rise in infections with multidrug-resistant Pseudomonas aeruginosa (MDR-PA) is a significant contributor to increased morbidity and mortality of…”
Get full text

Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study by Sertić, Zrinka, Lucijanic, Marko, Bašić-Kinda, Sandra, Serventi Seiwerth, Ranka, Periša, Vlatka, Sertić, Dubravka, Coha, Bozena, Pulanic, Drazen, Šegulja, Dragana, Rogić, Dunja, Valkovic, Toni, Aurer, Igor, Durakovic, Nadira

“…Background Patients with hematologic malignancy have a higher risk of death from COVID-19 compared to the general population. A blunted immune response from…”
Get full text

Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease by Aurer, Igor, Radman, Ivo, Nemet, Damir, Zupancić-Salek, Silva, Bogdanić, Vinko, Mrsić, Mirando, Sertić, Dubravka, Labar, Boris

“…Patients with refractory Hodgkin's disease or relapsing after high-dose therapy and autografting have a poor prognosis. Here, we present our experiences with…”
Get more information

Incidence of Secondary Primary Malignancies after Long-Term Follow up of Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation - Report from Croatian Cooperative Group for Hematologic Malignancies (KroHem) by Batinic, Josip, Dreta, Barbara, Radić-Krišto, Delfa, Galusic, Davor, Sinčić Petričević, Jasminka, Holik, Hrvoje, Krecak, Ivan, Morić Perić, Martina, Zekanović, Ivan, Piršić, Mario, Jakšić, Ozren, Rinčić, Goran, Valković, Toni, Sertić, Dubravka, Serventi Seiwerth, Ranka, Rončević, Pavle, Bojanić, Ines, Berneš, Petra, Romić, Ilenia, Mazić, Sanja, Bašić-Kinda, Sandra

“…Background: Autologous stem cell transplantation (ASCT) after induction treatment is standard of care for multiple myeloma (MM) for the last 30 years. Two…”
Get full text

Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study by Radman, Ivo, Kovacević-Metelko, Jasminka, Aurer, Igor, Nemet, Damir, Zupancić-Salek, Silva, Bogdanić, Vinko, Sertić, Dubravka, Mrsić, Mirando, Pulanić, Roland, Gasparović, Vladimir, Labar, Boris

“…To evaluate the role of surgical resection in the treatment of patients with primary gastrointestinal non-Hodgkin s lymphoma in our institution. The…”
Get full text

Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms by Horvat, Ivana, Boban, Ana, Zadro, Renata, Antolic, Margareta Radic, Serventi-Seiwerth, Ranka, Roncevic, Pavle, Radman, Ivo, Sertic, Dubravka, Vodanovic, Marijo, Pulanic, Drazen, Basic-Kinda, Sandra, Durakovic, Nadira, Zupancic-Salek, Silva, Vrhovac, Radovan, Aurer, Igor, Nemet, Damir, Labar, Boris

“…In a study analyzing the difference between Philadelphia chromosome–negative patients with myeloproliferative neoplasms with and without thrombosis, we found a…”
Get full text

Anagrelide for treatment of patients with essential thrombocythaemia by Boban, Ana, Sertić, Dubravka, Radman, Ivo, Zupancić-Salek, Silva, Zadro, Renata, Labar, Boris

“…Anagrelide is an imidazokinazoline derivate that reduces platelet production by interfering with megakaryocyte proliferation and maturation. As a…”
Get full text

Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia by Mrsić, Mirando, Seiwerth, Ranka Serventi, Labar, Boris, Bogdanić, Vinko, Nemet, Damir, Duraković, N, Mikulić, M, Sertić, Dubravka, Aurer, Igor, Radman, I, Zupancić-Salek, Silva

“…Aplastic anemia is a bone marrow disease characterized by marrow aplasia and pancytopenia. Because hematopoietic stem cell transplantation (HSCT) cures severe…”
Get full text

Treatment of acute leukemia with allogeneic stem cell transplantation by Seiwerth, Ranka Serventi, Mrsić, Mirando, Nemet, Damir, Bogdanić, Vinko, Mikulić, Mirta, Sertić, Dubravka, Grković, Lana, Cecuk, Esma, Bojanić, Ines, Batinić, Drago, Labar, Boris

“…Allogeneic hematopoietic stem cell transplantation is a standard therapeutic option in the treatment of patients with malignant hematologic diseases and some…”
Get full text

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study by Ostojic, Alen, Sertic, Dubravka, Roncevic, Pavle, Peric, Zinaida, Granic, Paula, Matic, Nikolina, Basic-Kinda, Sandra, Serventi-Seiwerth, Ranka, Radman, Ivo, Zadro, Renata, Nemet, Damir

“…Imatinib has been the standard of care in chronic myelogenous leukemia for 15 years. Its optimal plasma concentration correlates with optimal disease response…”
Get full text

Current approach to diagnosis and treatment of acute leukemia in adults by Labar, Boris, Nemet, Damir, Sucić, Mate, Batinić, Drago, Zadro, Renata, Mrsić, Sanja, Serventi-Seiwerth, Ranka, Sertić, Dubravka, Mikulić, Mirta, Duraković, Nadira

“…Current classification of acute leukemia is based on morphology, immunophenotyping, cytogenetic and molecular abnormalities of leukemic cells. All these…”
Get full text

Clinical Utility of Heavy/Light Chain Assay for Evaluation and Prognostication in Multiple Myeloma Patients by Batinic, Josip, Peric, Zinaida, Segulja, Dragana, Last, James, Perkovic, Sanja, Dubravcic, Klara, Volaric, Lidija, Sertic, Dubravka, Radman, Ivo, Basic-Kinda, Sandra, Matisic, Danica, Batinic, Drago, Labar, Boris, Nemet, Damir

“…Objectives: To evaluate the clinical utility of the novel heavy/light chain immunoassay for the assessment of multiple myeloma patients. Methods: Serum samples…”
Get full text

Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry by Hoffmann, Verena Sophia, Baccarani, Michele, Hasford, Joerg, Lindoerfer, Doris, Burgstaller, Sonja, Sertic, Dubravka, Costeas, Paul, Mayer, Jiri, Indrak, Karel, Everaus, Hele, Koskenvesa, Perttu, Guilhot, Joelle, Schubert-Fritschle, Gabriele, Castagnetti, Fausto, Di Raimondo, Francesco, Lejniece, Sandra, Griskevicius, Laimonas, Thielen, Noortje, Sacha, Thomas, Hellmann, Andrzej, Turkina, Anna, Zaritskey, Andrey, Bogdanovic, Andrija, Sninska, Zuzana, Zupan, Irena, Casado, Felipe, Simonsson, Bengt, Clark, Richard E., Saussele, Susanne, Hochhaus, Andreas, Hehlmann, Ruediger

“…Introduction Clinical studies clearly show that treatment with tyrosine-kinase inhibitors (TKI) greatly improve the prognosis of patients with CML. Detailed…”
Get full text

Comparison of branded and generics imatinib plasma concentrations in patients with chronic myelogenous leukemia – unicentric study by Ostojic, Alen, Sertic, Dubravka, Roncevic, Pavle, Peric, Zinaida, Granic, Paula, Matic, Nikolina, Basic-Kinda, Sandra, Serventi-Seiwerth, Ranka, Radman, Ivo, Zadro, Renata, Nemet, Damir

“…Abstract Introduction For over a decade, imatinib has been the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML). Doubts…”
Get full text

Dose-Intense BACOP for Treatment of High Risk Peripheral T-Cell NHL (PTCL) by Aurer, Igor, Dujmovic, Dino, Radman, Ivo, Basic-Kinda, Sandra, Nemet, Damir, Ilic, Ivana, Stern-Padovan, Ranka, Santek, Fedor, Sertic, Dubravka

“…Abstract 4889 PTCLs, except ALK+ ALCL, have a bad prognosis with overall 5-year survival rates below 30%. Because of their relative rarity, no large randomized…”
Get full text